Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H HENDERSON

Showing results (481-490 of 547) with videos related to

Pageof 55
Sort By:
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 22, 2019
Patient-Reported Sexual Survivorship Following High-Dose Image-Guided Proton Therapy for Prostate CancerAdam L Holtzman, Curtis M Bryant, Nancy P Mendenhall, et al.
International Journal of Radiation Oncology, Biology, Physics|February 18, 2016
Proton Therapy as Salvage Treatment for Local Relapse of Prostate Cancer Following Cryosurgery or High-Intensity Focused UltrasoundAdam L Holtzman, Bradford S Hoppe, Haley P Letter, et al.
Plos Neglected Tropical Diseases|April 14, 2017
Application of a household-based molecular xenomonitoring strategy to evaluate the lymphatic filariasis elimination program in Tamil Nadu, IndiaSwaminathan Subramanian, Purushothaman Jambulingam, Brian K Chu, et al.
Acta Oncologica (Stockholm, Sweden)|March 13, 2013
Hypofractionated passively scattered proton radiotherapy for low- and intermediate-risk prostate cancer is not associated with post-treatment testosterone suppressionWhoon Jong Kil, Romaine C Nichols, Bradford S Hoppe, et al.
Acta Oncologica (Stockholm, Sweden)|January 24, 2018
Long-term outcomes following proton therapy for prostate cancer in young men with a focus on sexual healthClement K Ho, Curtis M Bryant, Nancy P Mendenhall, et al.
Acta Oncologica (Stockholm, Sweden)|May 13, 2020
Image-guided hypofractionated double-scattering proton therapy in the management of centrally-located early-stage non-small cell lung cancerShivam M Kharod, R Charles Nichols, Randal H Henderson, et al.
American Journal of Clinical Oncology|May 5, 2018
Rectal Culture and Sensitivity Analysis for Reducing Sepsis Risk After Fiducial Marker PlacementWilliam M Mendenhall, Gail Sarto, Curtis M Bryant, et al.
European Journal of Medicinal Chemistry|March 13, 2024
Imidazo[1,2-b]pyridazines as inhibitors of DYRK kinasesScott H Henderson, Fiona J Sorrell, James M Bennett, et al.
International Journal of Radiation Oncology, Biology, Physics|April 17, 2016
Five-Year Biochemical Results, Toxicity, and Patient-Reported Quality of Life After Delivery of Dose-Escalated Image Guided Proton Therapy for Prostate CancerCurtis Bryant, Tamara L Smith, Randal H Henderson, et al.
Plos Neglected Tropical Diseases|May 20, 2016
Programmatic Use of Molecular Xenomonitoring at the Level of Evaluation Units to Assess Persistence of Lymphatic Filariasis in Sri LankaRamakrishna U Rao, Sandhya D Samarasekera, Kumara C Nagodavithana, et al.
Pageof 55

Showing results (481-490 of 547) with videos related to

Sort By:
Pageof 55
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 22, 2019
Patient-Reported Sexual Survivorship Following High-Dose Image-Guided Proton Therapy for Prostate CancerAdam L Holtzman, Curtis M Bryant, Nancy P Mendenhall, et al.
International Journal of Radiation Oncology, Biology, Physics|February 18, 2016
Proton Therapy as Salvage Treatment for Local Relapse of Prostate Cancer Following Cryosurgery or High-Intensity Focused UltrasoundAdam L Holtzman, Bradford S Hoppe, Haley P Letter, et al.
Plos Neglected Tropical Diseases|April 14, 2017
Application of a household-based molecular xenomonitoring strategy to evaluate the lymphatic filariasis elimination program in Tamil Nadu, IndiaSwaminathan Subramanian, Purushothaman Jambulingam, Brian K Chu, et al.
Acta Oncologica (Stockholm, Sweden)|March 13, 2013
Hypofractionated passively scattered proton radiotherapy for low- and intermediate-risk prostate cancer is not associated with post-treatment testosterone suppressionWhoon Jong Kil, Romaine C Nichols, Bradford S Hoppe, et al.
Acta Oncologica (Stockholm, Sweden)|January 24, 2018
Long-term outcomes following proton therapy for prostate cancer in young men with a focus on sexual healthClement K Ho, Curtis M Bryant, Nancy P Mendenhall, et al.
Acta Oncologica (Stockholm, Sweden)|May 13, 2020
Image-guided hypofractionated double-scattering proton therapy in the management of centrally-located early-stage non-small cell lung cancerShivam M Kharod, R Charles Nichols, Randal H Henderson, et al.
American Journal of Clinical Oncology|May 5, 2018
Rectal Culture and Sensitivity Analysis for Reducing Sepsis Risk After Fiducial Marker PlacementWilliam M Mendenhall, Gail Sarto, Curtis M Bryant, et al.
European Journal of Medicinal Chemistry|March 13, 2024
Imidazo[1,2-b]pyridazines as inhibitors of DYRK kinasesScott H Henderson, Fiona J Sorrell, James M Bennett, et al.
International Journal of Radiation Oncology, Biology, Physics|April 17, 2016
Five-Year Biochemical Results, Toxicity, and Patient-Reported Quality of Life After Delivery of Dose-Escalated Image Guided Proton Therapy for Prostate CancerCurtis Bryant, Tamara L Smith, Randal H Henderson, et al.
Plos Neglected Tropical Diseases|May 20, 2016
Programmatic Use of Molecular Xenomonitoring at the Level of Evaluation Units to Assess Persistence of Lymphatic Filariasis in Sri LankaRamakrishna U Rao, Sandhya D Samarasekera, Kumara C Nagodavithana, et al.
Pageof 55